- Strong match: 3 shared modalities
- Strong match: 3 shared learner audiences
- Also shares: introductory level
- Also shares: hybrid delivery
Back to StakeholdersVisit Provider Michener Atma Journey Breakthrough Therapies Fungi Academy
Numinus
CategoriesClinical Research & Pipeline ProductsResearch, Drug Development & ManufacturingCare Delivery & Psychedelic FacilitationSpecialty & Outpatient ClinicsOnline ResourcesMedia, Education & EngagementCertification & Credentialing ProgramsTraining & Credentialing
Data updated
Enterprise Intelligence
Quarterly psychedelic drug-development briefing
Compare indication activity, programme milestones, competitive intensity, and near-term catalysts. Q2 includes quarter-over-quarter changes against the published Q1 baseline.
Numinus Wellness Inc. is a Vancouver-based mental health company focused on psychedelic-assisted therapy: it provides practitioner training, clinical research services, and (formerly) operated clinics and a Health Canada‑licensed bioscience laboratory for psychedelic research and product development.
IntroductoryHybridPremiumPsychedelic-assisted therapy trainingIntegration trainingContinuing educationOtherLicensed cliniciansAspiring practitionersOther
Blossom’s read
Numinus sits in the more clinically minded end of the psychedelic training field: practical, practitioner-led, and closely tied to its own therapy model and research background. It is best for regulated professionals who want structured introduction-to-intermediate training with continuing-education credit, rather than for the curious public. The name carries some weight through its in-house clinicians and leadership, though the training offer is more service-provider education than an independent academic school.
Who is Numinus for?
Best suited to mental health and medical professionals working, or planning to work, in psychedelic-assisted therapy. It also fits clinicians who want a modular pathway with live teaching, case-based learning, and CE credit.
What do you need before you start?
Numinus positions the courses for professionals and uses minimum platform and Zoom requirements. The materials do not publish a single universal licensure requirement on the training pages, but the content, credit structure, and certification pathway are aimed at practitioners rather than the general public.
Is Numinus accredited?
Numinus reports continuing-education recognition through the Canadian Psychological Association, Canadian Counselling and Psychotherapy Association, L’Ordre des psychologues du Québec, and the National Board for Certified Counsellors. Its training is also presented as approved for ASWB ACE social work continuing education. The Fundamentals course is described as offering 48 total CE credits, and the Applied course as offering 32 CE hours; the FAQ also notes that some course pages carry approval periods and that regulatory boards remain the final authority on credit acceptance.
How much does it cost?
Numinus does not publish a single programme price on the training pages surfaced here. Its policy materials note a 10% administration fee on cancellations, with refunds available only if cancelled at least 24 business hours before the start of training; credits may be applied to future courses within one calendar year.
What do you walk away with?
Learners are intended to leave with introductory competence in psychedelic-assisted therapy, including therapist stance, facilitation skills for preparation, medicine and integration sessions, trauma-aware practice, and the ability to respond to burnout, vicarious trauma, transference and countertransference. The provider also frames a certification pathway for practitioners, though the public pages here do not fully spell out the final credential on a single training page.
Clinical Care Delivery Snapshot
Specialty & Outpatient ClinicsProvider Model
Independent Specialty Clinic
Organization Status
Unknown
Psychedelic Services
Unknown
Service Coverage
Global
Service Profile
Care Settings
Specialty Outpatient Clinic
Payer Models
Unknown
Non-Psychedelic Service Mix
Unknown
Care Delivery Notes
Backfilled profile for existing L2 clinical care delivery stakeholder.
Ecosystem
1 connectionInvestors
MAPS
Bought-deal public offering (units)
Feb 16, 2024
$6 million (50,000,000 units at $0.12; up to $900,000 additional via over-allotment)
Numinus Wellness Inc. Announces $6 Million Bought Deal Public Offering with Leads Orders from MAPS and Integrated V.C.Similar course providers
Reference points selected from shared training modalities, learner audience, level, delivery format, pricing, and location.
- Strong match: 3 shared modalities
- Strong match: 3 shared learner audiences
- Also shares: hybrid delivery
- Also shares: premium pricing
- Strong match: 3 shared modalities
- Strong match: 2 shared learner audiences
- Also shares: hybrid delivery
- Also shares: premium pricing
- Strong match: 2 shared modalities
- Strong match: 3 shared learner audiences
- Also shares: introductory level
- Also shares: hybrid delivery
Quick Facts
- Type
- Public Biotech
- Founded
- 2019
- HQ
- Canada
- Website
- Visit